BlackRock’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,479,493
| Closed | -$54.7M | – | 6036 |
|
|
2022
Q2 | $54.7M | Sell |
3,479,493
-101,814
| -3% | -$1.55M | ﹤0.01% | 2423 |
|
|
2022
Q1 | $54.5M | Sell |
3,581,307
-32,289
| -0.9% | -$492K | ﹤0.01% | 2537 |
|
|
2021
Q4 | $55.5M | Buy |
3,613,596
+46,727
| +1% | +$615K | ﹤0.01% | 2592 |
|
|
2021
Q3 | $31.1M | Sell |
3,566,869
-85,000
| -2% | -$775K | ﹤0.01% | 2983 |
|
|
2021
Q2 | $37.3M | Sell |
3,651,869
-106,791
| -3% | -$1.13M | ﹤0.01% | 2884 |
|
|
2021
Q1 | $44.9M | Buy |
3,758,660
+234,873
| +7% | +$2.66M | ﹤0.01% | 2688 |
|
|
2020
Q4 | $32M | Buy |
3,523,787
+215,108
| +7% | +$1.66M | ﹤0.01% | 2747 |
|
|
2020
Q3 | $20.1M | Sell |
3,308,679
-59,772
| -2% | -$456K | ﹤0.01% | 2858 |
|
|
2020
Q2 | $29.9M | Buy |
3,368,451
+542,370
| +19% | +$4.68M | ﹤0.01% | 2583 |
|
|
2020
Q1 | $20.5M | Buy |
2,826,081
+68,259
| +2% | +$506K | ﹤0.01% | 2593 |
|
|
2019
Q4 | $24.3M | Buy |
2,757,822
+64,281
| +2% | +$481K | ﹤0.01% | 2773 |
|
|
2019
Q3 | $16.4M | Buy |
2,693,541
+27,267
| +1% | +$153K | ﹤0.01% | 2934 |
|
|
2019
Q2 | $11.1M | Buy |
2,666,274
+143,596
| +6% | +$757K | ﹤0.01% | 3185 |
|
|
2019
Q1 | $15.9M | Buy |
2,522,678
+174,916
| +7% | +$1.23M | ﹤0.01% | 2863 |
|
|
2018
Q4 | $15.2M | Buy |
2,347,762
+63,750
| +3% | +$488K | ﹤0.01% | 2870 |
|
|
2018
Q3 | $19M | Buy |
2,284,012
+56,063
| +3% | +$426K | ﹤0.01% | 2903 |
|
|
2018
Q2 | $13.9M | Buy |
2,227,949
+213,336
| +11% | +$1.36M | ﹤0.01% | 3072 |
|
|
2018
Q1 | $13.8M | Sell |
2,014,613
-8,202
| -0.4% | -$52.1K | ﹤0.01% | 2964 |
|
|
2017
Q4 | $13.3M | Sell |
2,022,815
-20,678
| -1% | -$126K | ﹤0.01% | 2998 |
|
|
2017
Q3 | $11.4M | Buy |
2,043,493
+18,818
| +0.9% | +$127K | ﹤0.01% | 3095 |
|
|
2017
Q2 | $15.6M | Buy |
2,024,675
+56,034
| +3% | +$473K | ﹤0.01% | 2914 |
|
|
2017
Q1 | $17.7M | Buy |
1,968,641
+1,961,428
| +27,193% | +$20.4M | ﹤0.01% | 2821 |
|
|
2016
Q4 | $78K | Sell |
7,213
-1,258
| -15% | -$16.8K | ﹤0.01% | 2706 |
|
|
2016
Q3 | $138K | Sell |
8,471
-7,046
| -45% | -$99.2K | ﹤0.01% | 2398 |
|
|
2016
Q2 | $148K | Buy |
15,517
+12,758
| +462% | +$139K | ﹤0.01% | 2278 |
|
|
2016
Q1 | $39K | Buy |
2,759
+2,076
| +304% | +$21.5K | ﹤0.01% | 2503 |
|
|
2015
Q4 | $7K | Sell |
683
-2,500
| -79% | -$22.6K | ﹤0.01% | 3055 |
|
|
2015
Q3 | $22K | Buy |
3,183
+2,500
| +366% | +$19.4K | ﹤0.01% | 2338 |
|
|
2015
Q2 | $6K | Buy |
+683
| New | +$5.18K | ﹤0.01% | 3091 |
|
Other funds holding NPTN
BlackRock's NPTN Position: Q3 2022 in Review
BlackRock sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 3,479,493 shares — an estimated $54.7M sold.
BlackRock first reported a position in NPTN in Q2 2015 and held it in 29 quarters. The position peaked at $55.5M in Q4 2021. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.
- BlackRock reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
- BlackRock sold 3,479,493 NEOPHOTONICS CORP shares in Q3 2022, an estimated $54.7M.
- BlackRock first reported a position in NEOPHOTONICS CORP in Q2 2015 and held it in 29 quarters.
- BlackRock's NEOPHOTONICS CORP position peaked at $55.5M in Q4 2021.
- 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.
Based on BlackRock's 13F filing for Q3 2022, filed 14 Nov 2022.